4Ebert W, Muley T,Trainer R,et al. Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with small cell lung cancer[J]. Anticancer Res,2002 ;22 (28) : 1083-9.
6Seemann MD, Beinert T, Furst H, et cd. An evaluation of the tumour markers, carcinoembryonic antigen ( CEA ) , cytokeratin marker ( CYFRA21-1) and neuron-specific enolase (NSE)in the differentiation of malignant from benign solitary pulmonary lesions [J]. Lung Cancer, 1999 ;26 : 149-55.
7Pujol JL, Boher JM, Grenier J, et al. Cyfra21-1, neuron specific enolase and prognosis of non-small cell lung cancer:prospective study in 621 patients[J]. Lung Cancer,2001 ;31:221-31.
5Dohmoto k, Hojo S, Fujita J, et al. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines[J]. Int J Cancer, 2001, 91(4): 468-473
6Dohmoto K, Hojo S, Fujita J, et al. Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines [J].Lung Cancer,2000, 30(1): 55-63
7Ando S, Kimura H, Iwai N, et al. Positive reaction for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer[J]. Antican-cer Res, 2003, 23(3c): 2869-2874
8Reinmuth N, Brandt B, Semik M, et al. Prognostic impact of Cyfra21-1 and other serum markers in completely resected nonsmall cell cancer(L)[J]. Lung Cancer, 2002, 36(3): 265-270
9TrapeJ, BuxoJ, Perez de Olaguer, et al. Tumor markers as prognostic factors in treated non-small cell lung cancer[J].Anticancer Res, 2003, 23(5b): 4277-4281
10Cioffi M, Vietri M, Gazzerro P, et al. Serum anti-p53 antibodies in lung cancer:comparison with established tumor markers [J].Lung Cancer, 2001, 33(2-3): 163-169
2Herbst RS, Heymach JY, Lippman SM. Molecular origins of cancer:lung cancer[ J]. N Engl J Med,2008 ;359 ( 13 ) : 1367-80.
3Pujol JL,Molinier O,Ebert W,et al. CYFRA21-1 is a prognostic determinant in non-small-cell lung cancer:resuhs of a meta-analysis in 2063 patients[J]. Br J Cancer,2004 ;90( 11 ) :2097-105.
4Jin B,Huang AM,Zhong RB ,et al. The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced nonsmall cell lung cancer[J]. Chemotherapy,2010;56(6) :417-23.
5Schneider J. Tumor markers in detection of lung cancer [J]. Adv Clin Chem ,2006 ;42( 1 ) : 1-41.
6Tomita M, Shimizu T, Ayabe T, et al. Prognostic significance of the com- bined use of preoperative platelet count and serum carcinoembryonic antigen level in non-small-cell lung cancer[J]. Gen Thorac Cardiovasc Surg,2010 ;58 ( 11 ) :573-6.
